Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meysam Moghbeli

Showing results (81-90 of 138) with videos related to

Pageof 14
Sort By:
Medical Oncology (Northwood, London, England)|August 22, 2025
Signaling pathways as the pivotal regulators of cisplatin resistance in tumor cells through SOX2 upregulationNegin Taghehchian, Iman Akhlaghipour, Amir Sadra Zangouei, et al.
Iranian Journal of Pathology|January 31, 2022
Kindlin1 As a Gender and Location-Specific Diagnostic Marker in Gastric Cancer PatientsMohammad Reza Abbaszadegan, Negin Taghehchian, Azadeh Aarabi, et al.
Pathology, Research and Practice|October 1, 2024
LINC00365 as a potential biomarker for total nephrectomy in advanced-stage renal cell carcinoma patientsFatemeh Taghavinia, Iman Akhlaghipour, Alireza Golshan, et al.
Pathology, Research and Practice|August 16, 2024
MicroRNA-135b mainly functions as an oncogene during tumor progressionFaezeh Tolue Ghasaban, Negin Taghehchian, Amir Sadra Zangouei, et al.
Diagnostic Pathology|April 27, 2021
MAEL as a diagnostic marker for the early detection of esophageal squamous cell carcinomaMohammad Reza Abbaszadegan, Negin Taghehchian, Azadeh Aarabi, et al.
Journal of Gastrointestinal Cancer|August 21, 2014
HES1 as an independent prognostic marker in esophageal squamous cell carcinomaShaghayegh Taleb, Mohammad Reza Abbaszadegan, Meysam Moghbeli, et al.
Journal of Gastrointestinal Cancer|May 5, 2016
Correlation Between Meis1 and Msi1 in Esophageal Squamous Cell CarcinomaMeysam Moghbeli, Abolfazl Rad, Moein Farshchian, et al.
Anti-Cancer Agents in Medicinal Chemistry|September 26, 2025
A Review of the Anticancer Properties of Cedrol and its Molecular MechanismsAli Mohammad Pourbagher Shahri, Sajad Sahab Negah, Meysam Moghbeli, et al.
Current Cancer Drug Targets|May 26, 2021
Single Nucleotide Polymorphisms as the Efficient Prognostic Markers in Breast CancerMaliheh Alimardani, Meysam Moghbeli, Azam Rastgar-Moghadam, et al.
Diagnostic Pathology|May 8, 2020
Genetics of blood malignancies among Iranian population: an overviewMajid Ghayour-Mobarhan, Amir Sadra Zangouei, Seyed Mohammad Hosseinirad, et al.
Pageof 14

Showing results (81-90 of 138) with videos related to

Sort By:
Pageof 14
Medical Oncology (Northwood, London, England)|August 22, 2025
Signaling pathways as the pivotal regulators of cisplatin resistance in tumor cells through SOX2 upregulationNegin Taghehchian, Iman Akhlaghipour, Amir Sadra Zangouei, et al.
Iranian Journal of Pathology|January 31, 2022
Kindlin1 As a Gender and Location-Specific Diagnostic Marker in Gastric Cancer PatientsMohammad Reza Abbaszadegan, Negin Taghehchian, Azadeh Aarabi, et al.
Pathology, Research and Practice|October 1, 2024
LINC00365 as a potential biomarker for total nephrectomy in advanced-stage renal cell carcinoma patientsFatemeh Taghavinia, Iman Akhlaghipour, Alireza Golshan, et al.
Pathology, Research and Practice|August 16, 2024
MicroRNA-135b mainly functions as an oncogene during tumor progressionFaezeh Tolue Ghasaban, Negin Taghehchian, Amir Sadra Zangouei, et al.
Diagnostic Pathology|April 27, 2021
MAEL as a diagnostic marker for the early detection of esophageal squamous cell carcinomaMohammad Reza Abbaszadegan, Negin Taghehchian, Azadeh Aarabi, et al.
Journal of Gastrointestinal Cancer|August 21, 2014
HES1 as an independent prognostic marker in esophageal squamous cell carcinomaShaghayegh Taleb, Mohammad Reza Abbaszadegan, Meysam Moghbeli, et al.
Journal of Gastrointestinal Cancer|May 5, 2016
Correlation Between Meis1 and Msi1 in Esophageal Squamous Cell CarcinomaMeysam Moghbeli, Abolfazl Rad, Moein Farshchian, et al.
Anti-Cancer Agents in Medicinal Chemistry|September 26, 2025
A Review of the Anticancer Properties of Cedrol and its Molecular MechanismsAli Mohammad Pourbagher Shahri, Sajad Sahab Negah, Meysam Moghbeli, et al.
Current Cancer Drug Targets|May 26, 2021
Single Nucleotide Polymorphisms as the Efficient Prognostic Markers in Breast CancerMaliheh Alimardani, Meysam Moghbeli, Azam Rastgar-Moghadam, et al.
Diagnostic Pathology|May 8, 2020
Genetics of blood malignancies among Iranian population: an overviewMajid Ghayour-Mobarhan, Amir Sadra Zangouei, Seyed Mohammad Hosseinirad, et al.
Pageof 14